ALTx Therapeutics
PrivateLast Round
Accelerator
Feb 5, 2026
Total Funding Raised
$17.05M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ALTx Therapeutics is a drug discovery company that develops precision cancer therapies targeting the Alternative Lengthening of Telomeres (ALT) pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALTx Therapeutics Comparables
Compare ALTx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessellate BIO | 89% | |
| Artios Pharma | 72% | |
| FoRx Therapeutics | 71% | |
ALTx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 5, 2026 |
ALTx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
| The Francis Crick Institute | Accelerator |
| Cancer Research Horizons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
$17M raised with participation from Syncona and Cancer Research Horizons.
ALTx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALTx Therapeutics's valuation, stock price, and market status.